Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III efficacy study of FLU D-QIV in children 6 to 35 months of age
2011-000758-41Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2011
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Fluarix Quadrivalent in influenza (2 arms), sponsored by GSK. Primary endpoint: First occurrence of RT-PCR confirmed moderate to severe influenza A and/or B disease due to any seasonal influenza strain. Started Jul 2011; status: completed.
02
Drugs
Fluarix Quadrivalent
03
Conditions
influenza
Beyond the preview
Go deeper on 2011-000758-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000758-41.